|
|
pSivida Limited is an Australian listed public company (ASX:
PSD) that is committed to the biomedical nanotechnology sectors.
It has as its core focus the development of nano-structured porous
silicon (BioSilicon™) for multiple potential applications
in human and animal healthcare through its UK operating subsidiary,
pSiMedica Limited.
pSivida shares were listed on the Australian Stock Exchange
Limited on 1 December 2000. The company has approximately 204
million
shares on issue.
back to top
|
Directors
Dr Roger Brimblecombe -
Non Executive Chairman
Mr Gavin Rezos -
Managing Director
Dr Roger Aston -
Director:
Research & Commercialisation
Company Secretary -
Mrs Nadine Donovan
|
Registered Office
Level 12, BGC Centre
28 The Esplanade
PERTH WA 6000
back to top
|
|
Legal Advisors (UK)
Nabarro Nathanson
Lacon House Theobald's Road
London WC1X 8RW
Tel: +44 20 7524 6000
Fax:+44 20 7524 6524
Legal Advisors (Australia)
Blake Dawson Waldron
Level 19 Forrest Centre
221 St George's Terrace
PERTH WA 6000
Tel: (08) 9366 8000
Fax: (08) 9366 8111
Legal Advisors (USA)
Mintz Levin Cohn Ferris
Glovsky and Popeo PC
Fersko's LLC
Chrysler Centre
666 Third Avenue
New York,
New York, 10017
|
|
back to top
|
Share Registry
Computer Share Registry Services
Pty Ltd
Level 2, Reserve Bank Building
45 St Georges Terrace
PERTH WA 6000
Tel: (+61 8) 9323 2000
Fax: (+61 8) 9323 2033
|
Bankers
HSBC Bank Australia Limited
188 St Georges Terrace
PERTH WA 6000
back to top
|
Auditors
Ernst & Young Chartered Accountants
Level 34 Central Park
152-158 St George's Terrace
PERTH WA 6000
Tel: (+61 8) 9429 2222
Fax: (+61 8) 9429 2436
|
Listings
Australian Stock Exchange: PSD
Frankfurt Stock Exchange: PSI
OFEX/International Market Service: PSD ABN: 78 009 232 026
back to top
|
|
|
[PRINT
THIS PAGE]